The vulnerable ventral tegmental area in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Introduction The involvement of dopaminergic neurons in the ventral tegmental area (VTA) in Parkinson’s disease (PD) has not been universally recognized by neuroscientists and neurologists. Here, we conduct a review of previous research documenting dopaminergic neuronal loss in both the substantia nigra pars compacta (SNpc) and VTA and add three new post-mortem PD cases to the literature. Methods PD and control brains were sectioned, stained for tyrosine hydroxylase, and cells in the SNpc and VTA were counted. Results Based on the review, we report two main results: 1) the VTA does degenerate in PD, and 2) the VTA degenerates less than the SNpc. Conclusion Inconsistent clinical information about these cases limits our ability to interpret how the VTA contributes to PD symptoms. However, our data in combination with prior PD neuropathological cases in the literature unequivocally establish that the VTA is involved in PD, and could be relevant for future investigation of non-motor symptoms in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529 · cited 1×
“However, on average the extent of dopaminergic degeneration is negligible when compared to that seen in PD [49].”
ResultThe Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246 · cited 1×
“Over 80% develop non-motor symptoms affecting mood, cognition, and sleep [15,36].”
BackgroundWeinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,019
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 6×
“Additionally, of the studies providing patient symptoms, two stated that all cases exhibited tremor, rigidity, and akinesia/hypokinesia [21,22], while another reported that approximately half of the cases presented with these symptoms [24].”
BackgroundInfluentialUnique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system
Lammel, S., Hetzel, A., Häckel, O., Jones, I., Liss, B., & Roeper, J. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.022 · Cited by 976 · cited 2×
“Due to the diversity of neurons, the VTA responds to local and distant neuromodulators [5].”
Background‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904 · cited 1×
“3 channels while those in the VTA express hyperpolarization-activated, cyclic nucleotide-regulated cation channels [29,30].”
BackgroundA review of Parkinson's disease
Davie, C. A. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn013 · Cited by 855 · cited 1×
“There is no debate as to whether the loss of neurons in the substantia nigra pars compacta (SNpc) is directly causative of the motor symptoms of PD [1].”
BackgroundArendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817 · cited 1×
“It has been reported in PD patients that dopamine levels are decreased by 70–90% [45,46], serotonin levels by 60% [46], norepinephrine levels by 80% [47], and acetylcholine levels by 70% [48].”
BackgroundNeuroanatomical and Neurochemical Substrates of Timing
Coull, J. T., Cheng, R.-K., & Meck, W. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.113 · Cited by 808
Cited by
Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
Chi, H., Chang, H.-Y., & Sang, T.-K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103082 · Cited by 412
Sundaram, S., Hughes, R. L., Peterson, E., Müller-Oehring, E. M., Brontë-Stewart, H. M., Poston, K. L., Faerman, A., Bhowmick, C., & Schulte, T. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.016 · Cited by 152
HCN2 channels in the ventral tegmental area regulate behavioral responses to chronic stress
Zhong, P., Vickstrom, C. R., Liu, X., Hu, Y., Yu, L., Yu, H.-G., & Liu, Q.-S. (2018) · eLife · doi:10.7554/elife.32420 · Cited by 99
“%) of comorbid depression in patients with Parkinson’s disease (Burn, 2002), which is characterized by the degeneration of midbrain dopaminergic neurons (Alberico et al., 2015).”
BackgroundKramer, D. J., Risso, D., Kosillo, P., Ngai, J., & Bateup, H. S. (2018) · eNeuro · doi:10.1523/eneuro.0152-18.2018 · Cited by 70
Watanabe, H., Dijkstra, J. M., & Nagatsu, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042009 · Cited by 48
Ahmadi, S.-A., Bötzel, K., Levin, J., Maiostre, J., Klein, T., Wein, W., Rozanski, V., Dietrich, O., Ertl-Wagner, B., Navab, N., et al. (2020) · NeuroImage: Clinical · doi:10.1016/j.nicl.2020.102185 · Cited by 31
Metadata
- Authors
- Alberico, S. L., Cassell, M. D., & Narayanan, N. S.
- Venue
- Basal Ganglia
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 5
- Issue
- 2-3
- Pages
- 51-55
- ISSN
- 2210-5336 (ISSN-L)
- OpenAlex
- W813036697
- Cited by
- 192
- References
- 56
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.